• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Rituximab Approval Information - Licensing Action

Proper name: Rituximab
Tradename: Rituxan
Manufacturer: IDEC Pharmaceutical Corp, San Diego, CA, License #1235
Indication for Use: Revise the dosage and administration section of the package insert to include information regarding the use of Rituximab as a component of the Zevalin therapeutic regimen
Approval Date: 2/19/2002
Type of submission: Biologics license application supplement


Label (Part 2)